Previous Article | Next Article 
Journal of Clinical Microbiology, August 2001, p. 2991-2994, Vol. 39, No. 8
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.8.2991-2994.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Possible Approach for Serodiagnosis of Ascariasis by Evaluation
of Immunoglobulin G4 Response Using Ascaris lumbricoides
Somatic Antigen
Tanusree
Bhattacharyya,1
Amal
Santra,2
Debendra N. Guha
Majumder,2 and
Bishnu P.
Chatterjee1,*
Department of Biological Chemistry, Indian Association for
the Cultivation of Science, Jadavpur, Calcutta 700 032,1 and Department of
Gastroenterology, Institute of Post Graduate Medical Education and
Research, Calcutta 700 020,2 India
Received 1 March 2001/Returned for modification 3 April
2001/Accepted 30 May 2001
 |
ABSTRACT |
Somatic antigen of Ascaris lumbricoides was purified to
homogeneity (molecular mass, 34 kDa) by ammonium sulfate fractionation and successive chromatographic procedures, namely, gel permeation, ion
exchange, and high-performance gel permeation liquid chromatographies. The antigen showed strong binding with immunoglobulin G (IgG) in
Ascaris-infested patients and was cross-reactive with IgE
and IgG in patients infested with other nematodes. It reacted
specifically with IgG4 (P < 0.001) in 63 Ascaris-infested patients, which represented 65% of
the total IgG response, though cross-reactivity with IgG1, IgG2, and
IgG3 subclasses was observed, indicating the unique specificity of this test system and its potential utility in the serodiagnosis of ascariasis.
 |
TEXT |
Ascaris lumbricoides
infects about one-fourth of the world's population (21)
and is considered to be one of the causes of various other ailments,
namely, intestinal obstruction, acute pancreatitis, acute appendicitis
(12), and malnutrition in children (9).
Despite the high prevalence of Ascaris infection, no good method for diagnosing ascariasis in the context of an epidemiological investigation has yet been devised except for parasitological screening
for the presence of eggs in stool. However, this method poses
logistical and social problems. The use of an alternative method, such
as serodiagnosis, is limited by the extensive cross-reactivity between
the antigenic epitopes of different nematodes infective to humans.
Ascariasis is associated with elevated immunoglobulin E (IgE) and IgG
responses in humans and animals (11, 24). Serological
tests based on IgG detection may overestimate the prevalence of
infection, due to the persistence of antibodies for a long time after
the deworming of patients. Although a novel, specific, and sensitive
technique for the serodiagnosis of ascariasis that involves the
assessment of Ascaris excretory-secretory (ES) antigen-specific IgG4 has been developed (3), procurement
of ES antigen from living worms is limited due to the small number and
death of the worms after deworming.
As a substance released from living worms, ES antigen possesses a
significant antibody response; however, the source of the ES antigen is
unknown. The possibility of its derivation from the worm's somatic
cell component could not be ruled out. If ES antigen responsible for
the IgG4 response in the infected host persists in the worm's somatic
cell component(s), this could be a chief alternative source of
IgG4-specific antigen for the diagnosis of ascariasis, due to its easy
availability from the whole worm rather than from the ES antigen.
The present study describes the purification of the A. lumbricoides somatic antigen and its reactivity with serum IgE and IgG, especially with subclasses of IgG by enzyme-linked immunosorbent assay (ELISA), which may be useful markers for diagnosis of
Ascaris infection in an epidemiological study.
Sixty-three patients (29 males and 34 females, 8 to 65 years of age)
from urban and rural areas of West Bengal, India, infested with
Ascaris were treated with albendazole (400-mg single dose), and during the first 72 h of their posttreatment period, stool samples were collected for three consecutive days from each subject and
examined under a microscope. The number of worms expelled (range, 1 to
50) was counted to provide an estimate of the worm burden for each
patient. Sera separated from pretreatment peripheral blood were stored
in aliquots at
50°C for analysis. For a comparison of the
parasitological screening with the serological evidence of ascariasis,
stool samples from 126 dyspeptic patients were collected for three
consecutive days and examined for the presence of eggs and/or larvae of
helminths as before. Ten subjects (six males and four females, 20 to 50 years of age) with no known history of worm infection and with an
absence of intestinal nematodes, confirmed by stool examination, served
as controls. Groups of 10 subjects (five males and five females, 5 to
40 years of age) infested with hookworm, Strongyloides
stercoralis, and Trichuris trichura, as confirmed by
stool tests, were studied. Sera from control subjects and
helminth-infested patients were stored at
50°C, and those
with mixed infections (i.e., those infested with more than one type of
nematode) were excluded from this study.
A. lumbricoides worms were collected from stool from each
patient, washed thoroughly with saline, and dissected longitudinally. The body wall of each worm was again washed, homogenized in
Tris-buffered saline (TBS; 50 mM, pH 8.0), centrifuged (10,000 rpm;
Sorvall RC5B refrigerated centrifuge) for 1 h at 4°C, and
concentrated (PM10 membrane). After protein estimation
(16), the solution was stored in aliquots at
50°C.
The extract was precipitated with ammonium sulfate to give products of
30, 70, and finally 100% saturation; these were centrifuged as before,
dissolved separately in TBS, dialyzed against the same buffer, and
tested for antigenicity by ELISA using sera from
Ascaris-infested patients. The most immunogenic fraction (30 to 70%, 1 ml, 20 mg of protein) was resolved into four fractions on a
Sephacryl S-300 column (1.6 by 90 cm) with TBS as the eluent; these
fractions were concentrated and tested for their binding activities
with specific IgE and IgG. Fraction III (0.5 ml, 0.5 mg of protein/ml), which showed high binding activity with specific IgE and IgG, was
further passed through a Resource-Q anion exchanger (6.4 by 30 mm) in a
fast protein liquid chromatography (FPLC) system with a continuous
gradient set up with TBS. The eluted fractions were concentrated and
assayed for antigenic activity as before. The more active fraction was
further purified by high-performance gel permeation liquid
chromatography (HPGPLC) on a protein PAC 300 SW column (7.5 by 75 mm)
with 10 mM phosphate-buffered saline (pH 6.8) as the eluent.
Homogeneity of the purified somatic antigen (pSAg) was tested by 7.5%
alkaline polyacrylamide gel electrophoresis (4). The
molecular size of pSAg was determined by sodium dodecyl sulfate (SDS)-7.5% polyacrylamide gel electrophoresis (14) with
the following protein markers: bovine serum albumin (66 kDa), ovalbumin (45 kDa), glyceraldehyde-3-phosphate dehydrogenase (36 kDa), carbonic anhydrase (29 kDa), trypsinogen (24 kDa), trypsin inhibitor (20 kDa),
lactalbumin (14 kDa), and aprotinin (6.5 kDa).
For ELISA, each fraction of SAg (10 µg/well) in carbonate buffer (pH
9.6), coated on a 96-well assay plate (Flow Laboratories) and blocked
with phosphate-buffered saline-Tween 20 (0.05%) containing bovine
serum albumin (1%), was incubated with sera from patients (100 µl),
which were diluted to 1:64. Biotinylated goat anti-human IgE, IgG,
IgG1, IgG2, IgG3, and IgG4 (Sigma), diluted to 1:1,000, were added,
following antibiotin-coupled peroxidase. Color developed by
o-phenylenediamine and H2O2 was
measured at 492 nm in an ELISA reader to quantify results. For the
ELISA inhibition assay, sera from patients, diluted to 1:100, were
incubated with SAg and its fractions prior to ELISA. Antigenic proteins
needed for inhibition were calculated from a graph of percentage
inhibition determined from ELISA reference values.
A nonparametric Mann-Whitney U test was used for testing the
significance of differences in worm load between sexes, and Spearman's rank correlation coefficient was used to assess the relation between age, isotype levels, and worm load.
The ammonium sulfate fraction of A. lumbricoides somatic
extract was separated into four fractions by Sephacryl S-300 column chromatography (Fig. 1a). Als III, being
the most immunogenic fraction, was separated into two fractions (Fig.
1b), of which Als IIIb, being the more immunogenic of the two fractions
as tested by an ELISA inhibition study, resulted in pSAg by HPGPLC
(Fig. 1c). pSAg-specific IgG and IgE were present in the sera of other nematode-infected patients (Fig. 2),
suggesting the nonspecificity of this test system; however, specific
IgG in Ascaris-infested patients was significantly elevated
(P < 0.05). pSAg was homogenous, having a molecular
size of
34 kDa (data not shown).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
(a) Gel permeation chromatography of the 30 to 70%
ammonium sulfate fraction of A. lumbricoides SAg on a
Sephacryl S-300 column. (b) Separation of Als III on a Resource-Q anion
exchanger by FPLC. (c) Purification of Als IIIb by HPGPLC on a protein
PAC 300 SW column. Abs., absorbance.
|
|

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 2.
pSAg-specific IgE and IgG response in patients with
different nematode infections. , control cut-off value for IgG; ,
control cut-off value for IgE. Dark gray bars, specific IgE response;
light gray bars, specific IgG response. A, A. lumbricoides;
H, hookworm; T, T. trichura; S, S. stercoralis;
C, control. Abs., absorbance.
|
|
The cross-reactivities in regard to IgE and IgG turned our attention
towards IgG subclass response in the study population, which showed
that pSAg predominantly reacted with IgG4 in the sera of 63 Ascaris-infested patients, comprising 65% of the total IgG
response; no such reactivity was observed with hookworm-, Trichuris-, and Strongyloides-infested patients
(P < 0.001) (Fig. 3).
Cross-reactivity was observed with pSAg-specific IgG1 (20% of
hookworm, 10% each of T. trichura and S. stercoralis), IgG2 (60% of hookworm, 80% of T. trichura, and 60% of S. stercoralis), and IgG3 (20%
of hookworm, 10% of T. trichura, and 30% of S. stercoralis).

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 3.
pSAg-specific IgG4 response by ELISA in sera of
different groups of individuals: Ascaris-infested
(n = 63), hookworm-infested (n = 10),
T. trichura-infested (n = 10), S. stercoralis-infested (n = 10), and control
(n = 10) subjects.
|
|
A comparison of the results of stool examination and of serological
evidence of ascariasis in 126 individuals (Table
1) shows that these results are
compatible and that such a comparison can be regarded a sensitive
assay. Figure 4 shows the relationship between absorbance levels of IgG4 response and worm loads of patients.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 4.
Relationship between absorbance levels of IgG4 response
and A. lumbricoides worm load. Abs., absorbance.
|
|
The Mann-Whitney U test showed no significant difference (P > 0.05) between males (n = 29) and females
(n = 34) regarding the worm load. Spearman's rank
correlation coefficient analyses also revealed no significant
association between isotypes, age, and worm load between sexes
(P > 0.05).
Adult A. lumbricoides worms produce pSAg-specific IgE and
IgG in infested humans. We observed significant cross-reactivity of
A. lumbricoides ES antigen, fraction Als IIIb, with IgE and IgG of different nematode-infected patients (3), which was not specific for serodiagnosis. The present study shows that, in
ascariasis, distribution of specific antibodies occurs among the IgG
subclasses and IgG4 response is highly elevated. IgG4 response was
studied in lymphatic filarial infections (13), onchocerciasis (5, 17), hookworm infection
(19), strongyloidiasis (22), and ascariasis
(3), and this subclass appears to be a marker of active
infection that is useful for serodiagnosis. In our
Ascaris-infested study population, IgG4 level was found to
be independent of the worm load. IgG4 antibody is prominent in total
antigen-specific IgG response when antigenic exposure is chronic
(1), and this finding is supported by results of several
clinical studies showing high IgG or IgG4 levels in subjects with
various atopic disorders (2, 6-8, 20, 23, 25) and chronic
schistosomiasis (10), as well as those with chronic filariasis (18). The fact that this immunoglobulin cannot
be induced in humans by the epitope phosphorylcholine, which is shared by all helminthic parasites (15), and consequently that
the possibilities of false-positive results are omitted, enables the assay system to be more predictive about Ascaris invasion.
Recombinant proteins, though they have been used for diagnostic
purposes, still show limitations in clinical tests and are high in cost
and not readily available in less developed regions, where the disease
is an important public health issue. In this regard, somatic antigen,
which contains epitope against specific IgG4 and is widely available,
may be considered an alternative diagnostic method of nominal expense
and no cross-reactivity. This increased specificity of an IgG4-based
assay may be used for serodiagnosis of ascariasis in large populations.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biological Chemistry, Indian Association for the Cultivation of
Science, 2A&B, Raja S. C. Mallik Rd., Jadavpur, Calcutta 700 032, India. Phone: 91-33-473-4971. Fax: 91-33-473-2805. E-mail:
bcbpc{at}mahendra.iacs.res.in.
 |
REFERENCES |
| 1.
|
Aalberse, R. C.,
R. Van Der Gaag, and J. Van Leeuwen.
1983.
Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response.
J. Immunol.
130:722-726[Abstract].
|
| 2.
|
Bruynzee, P. L. B., and L. Berrens.
1979.
IgE and IgG antibodies in specific human allergies.
Int. Arch. Allergy Appl. Immunol.
58:344-350[Medline].
|
| 3.
|
Chatterjee, B. P.,
A. Santra,
P. Roy Karmakar, and D. N. Guha Majumder.
1996.
Evaluation of IgG4 response in ascariasis by ELISA for serodiagnosis.
Trop. Med. Int. Health
1:633-639[Medline].
|
| 4.
|
Davis, B. J.
1964.
Disc-electrophoresis-II, method and application to human serum proteins.
Ann. N. Y. Acad. Sci.
121:404-427.
|
| 5.
|
Egwang, T. G.,
C. Nguiri,
M. Kombila,
T. H. Duong, and D. R. Lenoble.
1993.
Elevated antifilarial IgG4 antibody levels in microfilaremic and microfilaridermic Gabonese adults and children.
Am. J. Trop. Med. Hyg.
49:135-142.
|
| 6.
|
Gwynn, C. M.,
J. M. Smith,
G. L. Leon, and D. R. Stanworth.
1978.
Role of IgG4 subclass in childhood allergy.
Lancet
i:910-911.
|
| 7.
|
Gwynn, C. M.,
G. Smith,
L. Leon, and D. R. Stanworth.
1979.
IgE and IgG4 subclass in atopic families.
Clin. Allergy
9:119-123[CrossRef][Medline].
|
| 8.
|
Gwynn, C. M.,
T. Almosawi, and D. R. Stanworth.
1982.
Clinical association with serum allergen specific IgG4 antibodies.
Clin. Allergy
12:459-464[CrossRef][Medline].
|
| 9.
|
Hlaing, T.
1993.
Ascariasis and childhood malnutrition.
Parasitology
107:S125-S136.
|
| 10.
|
Iskander, R.,
P. K. Das, and R. C. Aalberse.
1981.
IgG4 antibodies in Egyptian patients with schistosomiasis.
Int. Arch. Allergy Appl. Immunol.
66:200-207[Medline].
|
| 11.
|
Jarrett, E. E. E., and H. R. P. Miller.
1982.
Production and activities of IgE in helminth infection.
Prog. Allergy
32:178-233.
|
| 12.
|
Khroo, M. S.
1996.
Ascariasis.
Gastroenterol. Clin. N. Am.
25:553-577[CrossRef][Medline].
|
| 13.
|
Kwan-Lim, G. E.,
K. P. Forsyth, and R. M. Maizels.
1990.
Filarial specific IgG4 response correlates with active Wuchereria bancrofti infection.
J. Immunol.
145:4298-4305[Abstract].
|
| 14.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 15.
|
Lal, R. B., and E. A. Ottesen.
1988.
Enhanced diagnostic specificity in human filariasis by IgG4 antibody assessment.
J. Infect. Dis.
158:1034-1037[Medline].
|
| 16.
|
Lowry, O. H.,
N. H. Rosebrough,
A. L. Farr, and R. J. Randall.
1951.
Protein measurement with the Folin phenol reagent.
J. Biol. Chem.
193:265-275[Free Full Text].
|
| 17.
|
Lucius, R.,
A. Kern,
F. Seeber,
T. Pogonka,
J. Willenbucher,
H. R. Taylor,
M. Pinder,
A. W. Ghalib,
H. Schulz-Key, and P. Soboslay.
1992.
Specific and sensitive IgG4 immunodiagnosis of onchocerciasis with a recombinant 33 kD Onchocerca volvulus protein (Ov 33).
Trop. Med. Parasitol.
43:139-145[Medline].
|
| 18.
|
Ottesen, E. A.,
E. Skvaril,
S. P. Tripathy,
R. W. Poindexter, and R. Hussain.
1985.
Prominence of IgG4 in the IgG antibody response to human filariasis.
J. Immunol.
134:2707-2712[Abstract].
|
| 19.
|
Palmer, D. L.,
M. Bradley, and D. A. Bundy.
1996.
IgG4 responses to antigens of adult Necator americanus. Potential for use in large scale epidemiological studies.
Bull. W. H. O.
74:381-386[Medline].
|
| 20.
|
Parish, W. E.
1981.
The clinical relevance of heat stable short term sensitizing anaphylactic IgG antibodies (IgGs-Ts) and of relative activities of IgG4 and IgG2.
Br. J. Dermatol.
105:223-231[CrossRef][Medline].
|
| 21.
|
Pawlowski, Z. S., and A. Davis.
1989.
Morbidity and mortality in ascariasis, p. 71-86.
In
D. W. T. Crompton, M. C. Nesheim, and Z. S. Pawlowski (ed.), Ascariasis and its prevention and control. Taylor and Francis, London, England.
|
| 22.
|
Ramachandran, S.,
R. W. Thompson,
A. A. Gam, and F. A. Neva.
1998.
Recombinant cDNA clones for immunodiagnosis of strongyloidiasis.
J. Infect. Dis.
177:196-203[Medline].
|
| 23.
|
Shakib, F.,
P. McLaughlan,
D. R. Stanworth,
E. Smith, and E. Fairburn.
1977.
Elevated serum IgE and IgG4 in patients with atopic dermatitis.
Br. J. Dermatol.
97:59-63[CrossRef][Medline].
|
| 24.
|
Stromberg, B. E.
1979.
IgE and IgG1 antibody production by a soluble product of Ascaris suum in the guinea pig.
Immunology
38:489-496[Medline].
|
| 25.
|
Van Toorenenbergen, A. W., and R. C. Aalberse.
1982.
Allergen-specific IgE and IgG4 antibody levels in sera and the capacity of these sera to sensitize the basophil leucocytes in vitro.
Clin. Allergy
12:451-458[CrossRef][Medline].
|
Journal of Clinical Microbiology, August 2001, p. 2991-2994, Vol. 39, No. 8
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.8.2991-2994.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.